Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells

H Morikawa1, K Fukuda, H Mima

  • 1Department of Anesthesia, Kyoto University Hospital, Japan.

Insights

Opioid receptor desensitization involves beta-adrenergic receptor kinase (betaARK) in NG108-15 cells. Serine/threonine phosphatases mediate the recovery of opioid receptor function after desensitization.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Signaling

Background:

  • Opioid receptors mediate crucial physiological functions, but their signaling can desensitize with prolonged exposure.
  • Understanding the molecular mechanisms of opioid receptor desensitization is vital for developing effective pain management strategies.
  • NG108-15 neuroblastoma x glioma hybrid cells provide a model system to study G protein-coupled receptor signaling.

Purpose of the Study:

  • To elucidate the mechanisms underlying the desensitization of opioid receptor-mediated calcium channel inhibition.
  • To investigate the role of specific kinases and phosphatases in the desensitization and resensitization processes.
  • To characterize the time course and concentration dependence of opioid-induced calcium channel current inhibition.

Main Methods:

  • Analysis of barium currents (I(Ba)) through calcium channels in NG108-15 cells using prolonged application of [D-Ala2, D-Leu5]enkephalin (DADLE).
  • Assessment of desensitization kinetics and concentration-dependence (EC50).
  • RNA blot and immunoblot analyses to detect beta-adrenoceptor kinase-1 (betaARK1) expression.
  • Pharmacological inhibition of betaARK (heparin), protein kinase A (PKA; Rp-cyclic AMPS, PKI), protein kinase C (PKC; phorbol ester), and serine/threonine phosphatases (okadaic acid).

Main Results:

  • DADLE-induced inhibition of I(Ba) desensitized by 57% with a time constant of 4.4 min, with maximal desensitization at 1 microM DADLE and an EC50 of 78 nM.
  • betaARK1 was expressed in NG108-15 cells.
  • Heparin significantly reduced desensitization magnitude and rate, while PKA and PKC inhibitors had no significant effect.
  • Recovery from desensitization (resensitization) occurred with a time constant of 6.7 min and was attenuated by okadaic acid.

Conclusions:

  • Opioid receptor desensitization in NG108-15 cells is a reversible process.
  • Beta-adrenergic receptor kinase (betaARK) plays a significant role in the desensitization of opioid receptor-mediated calcium channel inhibition.
  • Serine/threonine phosphatases are implicated in the resensitization process, while PKA and PKC are not directly involved.